Development of Better LNP-Based Genetic Medicines
Lipid nanoparticles (LNPs) are effective non-viral vectors, which are widely used delivery vehicles for genetic medicines. It is therefore important to understand and limit LNP-related impurities to help ensure genetic product integrity and mitigate risks to patient safety and product efficacy. To keep up with global demand, there is also a need to shorten development timelines for gene-based therapeutics and vaccines.
Download this eBook to learn more about:
- Critical quality attributes of LNPs
- mRNA and RNA purity
- Determination of oligonucleotide structures
- Characterization of lipids and related impurities
